Cost-Effectiveness Analysis for Cardiovascular Magnetic Resonance Imaging

Cost-impact of cardiac magnetic resonance imaging with Fast-SENC compared to SPECT in the diagnosis of coronary artery disease in the U.S

10.1080/13696998.2019.1580713 · doi-reference

Stress CMR imaging observation unit in the emergency department reduces 1-year medical care costs in patients with acute chest pain: a randomized study for comparison with inpatient care

10.1016/j.jcmg.2011.04.016 · doi-reference

The STRATEGY Study (Stress Cardiac Magnetic Resonance Versus Computed Tomography Coronary Angiography for the Management of Symptomatic Revascularized Patients): Resources and Outcomes Impact

10.1161/circimaging.116.005171 · doi-reference

Evidence-based cardiovascular magnetic resonance cost-effectiveness calculator for the detection of significant coronary artery disease

10.1186/s12968-021-00833-1 · doi-reference

Modeling the cost and health impacts of diagnostic strategies in patients with suspected transthyretin cardiac amyloidosis

10.1161/jaha.122.026308 · doi-reference

Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy

10.3310/hta18590 · doi-reference

10.1136/bmjopen-2013-003419

10.1136/bmjopen-2013-003419 · doi-reference

Cost-effectiveness in diagnosis of stable angina patients: a decision-analytical modelling approach

10.1136/openhrt-2021-001700 · doi-reference

Cost-effectiveness of cardiovascular imaging for stable coronary heart disease

10.1136/heartjnl-2020-316990 · doi-reference

Cost-effectiveness of functional cardiac imaging in the diagnostic work-up of coronary heart disease

10.1093/ehjqcco/qcw008 · doi-reference

Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial

10.1016/s0140-6736(11)61335-4 · doi-reference

Cost-effectiveness of cardiovascular magnetic resonance in the diagnosis of coronary heart disease: an economic evaluation using data from the CE-MARC study

10.1136/heartjnl-2013-303624 · doi-reference

Magnetic resonance perfusion or fractional flow reserve in coronary disease

10.1056/nejmoa1716734 · doi-reference

Cost-Minimization Analysis for Cardiac Revascularization in 12 Health Care Systems Based on the EuroCMR/SPINS Registries

10.1016/j.jcmg.2021.11.008 · doi-reference

Cost-minimization analysis of three decision strategies for cardiac revascularization: results of the “suspected CAD” cohort of the european cardiovascular magnetic resonance registry

10.1186/s12968-015-0222-1 · doi-reference

Prevalence and extent of obstructive coronary artery disease among patients undergoing elective coronary catheterization in New York State and Ontario

10.1001/jama.2013.7834 · doi-reference

Low diagnostic yield of elective coronary angiography

10.1056/nejmoa0907272 · doi-reference

Performance figures of invasive cardiology in Germany 2006 and 2007 focussing on coronary artery disease

10.1007/s00392-010-0244-5 · doi-reference

Comparative cost-effectiveness analyses of cardiovascular magnetic resonance and coronary angiography combined with fractional flow reserve for the diagnosis of coronary artery disease

10.1186/1532-429x-16-13 · doi-reference

10.1186/1532-429x-14-35

10.1186/1532-429x-14-35 · doi-reference

Cost-effectiveness of cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary artery disease in Germany

10.1186/1532-429x-15-30 · doi-reference

Fractional flow reserve versus angiography for guiding percutaneous coronary intervention

10.1056/nejmoa0807611 · doi-reference

Cost-effectiveness analysis of stress cardiovascular magnetic resonance imaging for stable chest pain syndromes

10.1016/j.jcmg.2020.02.029 · doi-reference

The optimal imaging strategy for patients with stable chest pain: a cost-effectiveness analysis

10.7326/m14-0027 · doi-reference

Cost-effectiveness analysis in the assessment of diagnostic imaging technologies

10.1148/radiol.2352040330 · doi-reference

ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines

10.1016/j.jacc.2014.03.016 · doi-reference

Economic foundations of cost-effectiveness analysis

10.1016/s0167-6296(96)00506-1 · doi-reference

Cost-effectiveness Thresholds Used by Study Authors, 1990-2021

10.1001/jama.2023.1792 · doi-reference

The influence of time horizon on results of cost-effectiveness analyses

10.1080/14737167.2017.1331432 · doi-reference

The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine

10.1001/jama.1996.03540140060028 · doi-reference

Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine

10.1001/jama.1996.03540160061034 · doi-reference

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

10.1001/jama.1996.03540150055031 · doi-reference

Cost, effectiveness, and cost-effectiveness

10.1161/circoutcomes.108.793406 · doi-reference

Measurement of health state utilities for economic appraisal

10.1016/0167-6296(86)90020-2 · doi-reference

Foundations of cost-effectiveness analysis for health and medical practices

10.1056/nejm197703312961304 · doi-reference

Cost-effectiveness analysis for imaging techniques with a focus on cardiovascular magnetic resonance

10.1186/1532-429x-15-52 · doi-reference

Cardiovascular imaging payment and reimbursement systems: understanding the past and present in order to guide the future

10.1016/j.jcmg.2014.01.008 · doi-reference

Medicare services provided by cardiologists in the United States: 1999-2008

10.1161/circoutcomes.111.961813 · doi-reference

Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association

10.1161/cir.0000000000001123 · doi-reference